"The 22-year-old CEO and founder of Theranos said Monday she has raised in excess of $10 million in venture funding for her adverse drug monitoring device. ... It’s critical we be able to scale in volume,” Ms. Holmes said as the company is releasing product in bulk for use in oncology. “We’re also focused on other critical care application, where you have basically toxic drugs that need to be monitored for safety reasons." ... Theranos is the second company Ms. Holmes has started. In high school, she started a business to distribute to Asian universities C++ software, which uses a general-purpose language for computer programming."